Therefore, the protocol allograft biopsy currently remains the preferred tool to screen for subclinical tubulitis.
因此，移植活检目前仍作为亚临床小管损伤筛查的采用手段。
2
This study investigated whether urinary tubular injury biomarkers can detect subclinical tubulitis found in protocol biopsies allowing for a noninvasive screening procedure.
这项研究探讨肾小管损伤的生物标记是否可在实验设计中检测出亚临床小管损伤从而考虑行无创性的筛查操作。
3
CONCLUSIONS: None of the investigated biomarkers allow for clear differentiation between stable transplants with normal tubular histology and stable transplants with subclinical tubulitis.